Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes

被引:48
|
作者
Monnier, Vincent M. [1 ,2 ]
Sun, Wanjie [3 ]
Gao, Xiaoyu [3 ]
Sell, David R. [1 ]
Cleary, Patricia A. [3 ]
Lachin, John M. [3 ]
Genuth, Saul [4 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[3] George Washington Univ, Ctr Biostat, Rockville, MD USA
[4] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
AGEs; A1c; DCCT/EDIC; Coronary artery calcium; Intima media thickening; Cardiac indices; CARBOXYMETHYL-LYSINE; CROSS-LINKING; END-PRODUCTS; COMPLICATIONS; GLUCOSEPANE; GLYCOXIDATION; CALCIFICATION; INTERVENTIONS; ACCUMULATION; PARTICIPANTS;
D O I
10.1186/s12933-015-0266-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We recently reported strong associations between eight skin collagen AGEs and two solubility markers from skin biopsies obtained at DCCT study closeout and the long-term progression of microvascular disease in EDIC, despite adjustment for mean glycemia. Herein we investigated the hypothesis that some of these AGEs (fluorescence to be reported elsewhere) correlate with long-term subclinical cardiovascular disease (CVD) measurements, i.e. coronary artery calcium score (CAC) at EDIC year 7-9 (n = 187), change of carotid intima-media thickness (IMT) from EDIC year 1 to year 6 and 12 (n = 127), and cardiac MRI outcomes at EDIC year 15-16 (n = 142). Methods: Skin collagen AGE measurements obtained from stored specimens were related to clinical data from the DCCT/EDIC using Spearman correlations and multivariable logistic regression analyses. Results: Spearman correlations showed furosine (early glycation) was associated with future mean CAC (p < 0.05) and CAC > 0 (p = 0.39), but not with CAC score < 100 vs. > 100. Glucosepane and pentosidine crosslinks, methylglyoxal hydroimidazolones (MG-H1) and pepsin solubility (inversely) correlated with IMT change from year 1 to 6(all P < 0.05). Left ventricular (LV) mass (cMRI) correlated with MG-H1, and inversely with pepsin solubility (both p < 0.05), while the ratio LV mass/end diastolic volume correlated with furosine and MG-H1 (both p < 0.05), and highly with CML (p < 0.01). In multivariate analysis only furosine (p = 0.01) was associated with CAC. In contrast IMT was inversely associated with lower collagen pepsin solubility and positively with glucosepane, Conclusions: In type 1 diabetes, multiple AGEs are associated with IMT progression in spite of adjustment for A1c implying a likely participatory role of glycation and AGE mediated crosslinking on matrix accumulation in coronary arteries. This may also apply to functional cardiac MRI outcomes, especially left ventricular mass. In contrast, early glycation measured by furosine, but not AGEs, was associated with CAC score, implying hyperglycemia as a risk factor in calcium deposition perhaps via processes independent of glycation.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes
    Vincent M Monnier
    Wanjie Sun
    Xiaoyu Gao
    David R Sell
    Patricia A Cleary
    John M Lachin
    Saul Genuth
    Cardiovascular Diabetology, 14
  • [2] Erratum to: Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes
    Vincent M Monnier
    Wanjie Sun
    Xiaoyu Gao
    David R Sell
    Patricia A Cleary
    John M Lachin
    Saul Genuth
    Cardiovascular Diabetology, 14
  • [3] Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes (vol 14, 118, 2015)
    Monnier, Vincent M.
    Sun, Wanjie
    Gao, Xiaoyu
    Sell, David R.
    Cleary, Patricia A.
    Lachin, John M.
    Genuth, Saul
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [4] Skin collagen advanced glycation endproducts (AGEs) as prospective markers of sub-clinical cardiovascular disease (CVD) outcomes in type 1 diabetes
    Monnier, V. M.
    Sun, W.
    Sell, D. R.
    Cleary, P. A.
    Lachin, J. M.
    Genuth, S. M.
    DIABETOLOGIA, 2013, 56 : S14 - S14
  • [5] The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes
    Monnier, Vincent M.
    Genuth, Saul
    Sell, David R.
    GLYCOCONJUGATE JOURNAL, 2016, 33 (04) : 569 - 579
  • [6] The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes
    Vincent M. Monnier
    Saul Genuth
    David R. Sell
    Glycoconjugate Journal, 2016, 33 : 569 - 579
  • [7] Circulating advanced glycation endproducts (AGEs) an indicator of long-term glycemic control
    Makita, Z
    Takeuchi, M
    Tsuchida, K
    Obara, S
    Miyoshi, H
    Koike, T
    DIABETES, 1999, 48 : A351 - A351
  • [8] Skin Advanced Glycation Endproducts (AGEs) are Increased at Onset in Children With Type 1 Diabetes (T1D)
    Baez, Eileen
    Shah, Shreepal
    Felipe, Dania
    Maynard, John D.
    Hempe, James
    Chalew, Stuart
    DIABETES, 2013, 62 : A349 - A349
  • [9] Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth
    Baez, Eileen A.
    Shah, Shreepal
    Felipe, Dania
    Maynard, John
    Lefevre, Suzanne
    Chalew, Stuart A.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2015, 28 (1-2): : 133 - 137
  • [10] Familial Association of Skin Advanced Glycation Endproducts (AGEs) in Youth With Type 1 Diabetes (T1D)
    Baez, Eileen
    Shah, Shreepal
    Felipe, Dania
    Maynard, John D.
    Hempe, James
    Chalew, Stuart
    DIABETES, 2013, 62 : A353 - A353